Table: RaQualia Pharma -2019 group forecast
Sept 6 (Reuters) -
RaQualia Pharma Inc
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2019 Dec 31, 2019
LATEST PREVIOUS
FORECAST FORECAST
Sales 1.76 2.02
Operating loss 84 mln 187 mln
Recurring loss 82 mln 195 mln
Net loss 106 mln 153 mln
EPS loss 5.13 yen 7.52 yen
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T